From SAMSHA: Updated TIP 63 -- Medications for Opioid Use Disorder

New Publication: August 3, 2021

This updated version of Treatment Improvement Protocol (TIP) 63: Medications for Opioid Use Disorder reviews the use of the three Food and Drug Administration-approved medications used to treat Opioid Use Disorder (OUD)—methadone, naltrexone, and buprenorphine—and other strategies and services needed to support recovery for people with OUD.

Updates include–

  • Additional information about the qualifications of practitioners who are eligible to apply for a waiver to prescribe buprenorphine (i.e., clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives) that explains exceptions under the latest buprenorphine practice guidelines on obtaining a waiver.

  • Citations that support induction onto extended-release naltrexone of people with positive urine tests for opioids so long as they pass the naloxone challenge.

  • Clarification that naltrexone can result in decreased opioid cravings.

  • Where needed, clarification of whether discussion about naltrexone refers to the oral formulation or the extended-release injectable formulation.

  • Updated statistics on opioid-related deaths, overdoses, accidents, and hospitalizations.

View publication at this link.

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.